昌吉周末妇科检查(昌吉女子医院做人流要多少钱) (今日更新中)

LOS ANGELES, March 16 (Xinhua) -- The death rate in the United States reached an all-time low in 2009, dropping 2.3 percent from 2008, a newly released report said.This was the 10th straight year of decline, demonstrating that Americans are living longer than ever, according to the report from the U.S. Centers for Disease Control and Prevention's National Center for Health Statistics.The nation saw a drop from 758.7 deaths per 100,000 people in 2008 to 741 per 100,000 people in 2009 when 2,436,682 deaths were reported, said the report published by HealthDay News on Wednesday.However, life expectancy for blacks remained unchanged -- 70.9 years for men and 77.4 years for women. The disparity between whites and blacks is now 4.3 years, representing a 0.2 percent increase from 2008 to 2009, the report found.The report said that deaths fell in 10 of the 15 leading causes of death -- heart disease dropped 3.7 percent, cancer fell 1.1 percent, and stroke declined 4.2 percent.Deaths from Alzheimer's disease, diabetes, chronic lower respiratory diseases and accidents all declined 4.1 percent, according to the report.Deaths from flu and pneumonia fell 4.7 percent, and deaths from septicemia, a bacterial infection, decreased 1.8 percent, the report said.Deaths from homicides fell 6.8 percent, but suicides increased from 35,933 in 2008 to 36,547 in 2009. Other than suicide, which overtook septicemia as the 10th leading cause of death, the ranking of the leading causes of death was unchanged from 2008 to 2009, the report noted.Infant mortality hit a record low in 2009, falling from 6.59 deaths per 1,000 births in 2008 to 6.42, representing a 2.6 percent decrease, according to the report.The report, however, did not give reasons for these trends.Experts think behavioral changes, particularly the decline in smoking, are partly responsible for the improvements.The report's lead author Kenneth Kochanek, a statistician at the center, said this is preliminary data, and the final data, which should be available this summer, may shed some light on the findings.

WASHINGTON, May 20 (Xinhua) -- The U.S. Food and Drug Administration (FDA) on Friday approved Sutent to treat patients with progressive neuroendocrine cancerous tumors located in the pancreas that cannot be removed by surgery or that have spread to other parts of the body.Neuroendocrine tumors found in the pancreas are slow-growing and rare. It is estimated that there are fewer than 1,000 new cases in the United States each year.This is the second new approval by the FDA to treat patients with this disease. On May 5, the agency approved Afinitor."FDA believes it is important to provide cancer patients with as many treatment options as possible," said Richard Pazdur, director of the Office of Oncology Drug Products in the FDA's Center for Drug Evaluation and Research. "The agency is committed to working with companies to bring innovative new therapies to the market and encourages companies to continue exploring additional uses for approved products."The safety and effectiveness of Sutent was established in a single study of 171 patients with metastatic (late-stage) or locally advanced (disease that could not be removed with surgery) disease who received Sutent or a placebo (sugar pill). The study was designed to measure the length of time a patient lived before their disease spread or worsened (progression-free survival).Results from the study demonstrate that Sutent provided benefit to patients by prolonging the median length of time they lived without the cancer spreading or worsening to 10.2 months compared to 5.4 months for patients who received placebo.In patients treated with Sutent for neuroendocrine pancreatic tumors, the most commonly reported side effects included diarrhea, nausea, vomiting, fatigue, anorexia, high blood pressure, energy loss, stomach pain, changes in hair color, inflammation of the mouth, and a decrease in infection-fighting white blood cells.Sutent is marketed by New York City-based Pfizer.

SAN FRANCISCO, May 3 (Xinhua) -- Microsoft announced on Tuesday that its Bing search engine will become the default search and mapping application on Blackberry phones.Microsoft Chief Executive Officer Steve Ballmer announced the partnership with Research in Motion (RIM), which makes Blackberry phones, at the Blackberry World Conference in Orlando, Florida, according to a Microsoft blog post.Ballmer said Microsoft would invest uniquely in the Blackberry platform in addition to its own Windows Phone platform."Bing will be deeply integrated at the BlackBerry OS (operating system) level," Ballmer said.Central to the collaboration, Blackberry devices will use Bing as the preferred search provider in the browser, and Bing will be the default search and map application for new devices presented to mobile operators, both in the United States and internationally, said Microsoft's Bing team in the blog post.Meanwhile, Bing is also shipping as the default search experience and map application for the newly released Blackberry Playbook, a RIM tablet computer which made market debut on April 19.On Tuesday's Blackberry conference, Ballmer called Google's Android ecosystem "chaos" and the Apple iOS "limited" before he hailed Windows Phone 7 and Blackberry. Microsoft and RIM are both competing with Apple, which makes the iPhone and iPad, and Google, which makes the Android operating system for smartphones and tablets in the booming mobile device market.

WASHINGTON, May 17 (Xinhua) -- A variation in a gene involved in regulating cholesterol in the bloodstream also appears to affect progesterone production in women, making it a likely culprit in a substantial number of cases of their infertility, a new study from Johns Hopkins University researchers suggests.The Hopkins group has also developed a simple blood test for this variation of the scavenger receptor class B type 1 gene ( SCARB1) but emphasized there is no approved therapy yet to address the problem in infertile women.Following up studies in female mice that first linked a deficiency in these receptors for HDL -- the so-called "good" or " healthy" cholesterol -- and infertility, researchers report finding the same link in studies of women with a history of infertility.The findings has been published on-line this week in the journal Human Reproduction.If the new study's findings hold up on further investigation, the John Hopkins team says they not only will offer clues into a genetic cause of some infertility, but could also lead to a treatment already shown to work in mice."Infertility is fairly common and a lot of the reasons for it are still unknown," warns endocrinologist Annabelle Rodriguez, an associate professor of medicine at the Johns Hopkins University School of Medicine and the lead author. "Right now, the benefit of this research is in knowing that there might be a genetic reason for why some women have difficulty getting pregnant. In the future, we hope this knowledge can be translated into a cure for this type of infertility."

LONDON, March 15 (Xinhua) -- The moon would be in a "super position" on Saturday, which makes it a "supermoon" and the web is awash with myths about its implications such as connection to recent earthquakes, but that's not the case according to British experts.Technically the so-called "supermoon" means that the moon would be in its perigee, the closest point to earth in its orbit on March 19, and on top of that, it would also be a full moon at the same time.The massive earthquake in Japan just fueled the speculation that the gravitational pull of the "supermoon" will bring chaos to the Earth, such as earthquakes and volcanic activities.But "there is little that is special about perigee on March 19," said Dr. Robert Massey, deputy executive secretary of the Royal Astronomical Society. He said the moon will be around 360,000 km from the earth on that day, but this has happened at least 15 times during the last 400 years."There is no reason whatsoever to believe that there is a connection between the so-called 'supermoon' and the recent earthquake," Massey told Xinhua. "There are also no other 'abnormal' phenomena connected with a 'supermoon' other than the high tides that we experience twice every month."Massey was echoed by Dr. Bruce Malamud, a geophysicist in the Department of Geography at King's College London, who that: "A supermoon will not be able to actually influence at all the internal workings of our Planet Earth, as there is so much momentum and mass already stored up, that the actual effect is negligible.""The earthquake took place a full 8 days before the 'supermoon' meaning that the tidal forces exerted by the moon and sun together were near their minimum rather than maximum level, directly contradicting the fearmongers," said Massey.Calling the "supermoon" claims "bogus science," he questioned the motives of those who made such claims on the day that thousands of people died in a severe earthquake and the ensuing tsunami.

来源：资阳报